Association Between Leptin and Risk of Lung Cancer

Xiang Tong,Yao Ma,Zhipeng Yan,Hong Fan
DOI: https://doi.org/10.1183/13993003.congress-2016.pa2869
IF: 24.3
2016-01-01
European Respiratory Journal
Abstract:Introduction: Lung cancer (LC) is the most commonly diagnosed cancer, and the prognosis of LC is poor. Increasing studies focused on exploring promising bio-markers for early diagnosis of LC. Some studies have demonstrated that the leptin may played a vital role in pathogenesis of colorectal cancer. However, it remains unclear whether the leptin was associated with LC risk. Objectives: The study aims tocomprehensively investigate the relationship between leptin and LC risk by meta-analysis. Methods: The standardized mean difference (SMD) and odds ratio (OR) with 95% confidence interval (CI) were used to assess the strength of these relationship. Results: In total, 24 studies included in the meta-analysis. The overall results found no statistically significant association between the serum leptin levels and LC risk (SMD=0.05, 95%CI=-0.48-0.58, P=0.85). However, the subgroup analysis results indicated that there is a significant higher circulating leptin levels in Chinese patients than healthy controls (SMD=0.61, 95%CI=0.07-1.15, P=0.03), but not in Europeans. Furthermore, we investigated whether the leptin expression levels in lung tissue were associated with the risk of LC. The results suggested that expression levels of leptin in the LC tissue were statistically higher than those in normal tissue among Chinese (OR=7.35, 95%CI=5.21-10.39, P<0.001). The statistically similar results were obtained by sensitivity analysis suggesting stability of the meta-analysis. Conclusions: The study suggested the leptin may played an important role in the mechanism of LC, especially in Chinese. To confirmed the results, more well designed studies involving thousands of patients are required.
What problem does this paper attempt to address?